These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1162 related articles for article (PubMed ID: 32631716)

  • 1. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
    Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
    ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
    Forster R; Stewart M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
    ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
    JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
    Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
    Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
    Cao YB; Zhang JD; Shen H; Jiang YY
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1099-108. PubMed ID: 20812009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
    Li XM; Sun SG; Zhang WD
    Chin Med J (Engl); 2012 Jul; 125(13):2339-45. PubMed ID: 22882859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
    Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
    Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
    Fuji T; Ochi T; Niwa S; Fujita S
    J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and safety of direct oral anticoagulants compared to conventional pharmacologic thromboprophylaxis in hip fracture patients: A systematic review and meta-analysis of randomized controlled trials.
    Abatzis-Papadopoulos M; Tigkiropoulos K; Nikas S; Papoutsis I; Kostopoulou O; Stavridis K; Karamanos D; Lazaridis I; Saratzis N
    Orthop Traumatol Surg Res; 2023 Apr; 109(2):103364. PubMed ID: 35817368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Rivaroxaban and Enoxaparin for Thromboprophylaxis Among Total Hip Arthroplasty Patients: A Systematic Review and Meta-Analysis.
    Wang C; Lan S; Xie P; Yang R
    Z Orthop Unfall; 2024 Aug; 162(4):368-381. PubMed ID: 36716770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
    Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
    BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is chemoprophylaxis required after total knee and total hip arthroplasty in the Asian population? A systematic review and network meta-analysis.
    Xu S; Chen JY; Zheng Q; Shi L; Tan AHC
    Thromb Res; 2021 Feb; 198():86-92. PubMed ID: 33302212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
    Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
    Holmes M; Carroll C; Papaioannou D
    Health Technol Assess; 2009 Sep; 13 Suppl 2():55-62. PubMed ID: 19804690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.